Market Access Balancing efficiency with risks: How biopharma companies can... AI technologies can enable companies to program, rather than write, submissions to health authorities.
Digital Asking the right questions around AI, with Brian Alexander, ... At BIO 2025, editor-in-chief Jonah Comstock spoke with Brian Alexander, CEO of Valo Health, about how he’s seeing the AI conversation evolve.
Digital Beyond AI hype: How dynamic study forecasting is helping pha... The industry must move beyond hype and address the real-world applications of AI for accurate enrolment forecasting.
Digital Sponsored One assistant to rule them all? Why the future of work is pl... How many tools do you usually use at work? One to two, or is it closer to five or six?
Sales & Marketing The 2025 way forward: What can UK healthcare advertising exp... Buoyed by growth opportunities and the strengthening economy, 2024 turned out to be an interesting year for the United Kingdom’s (UK) healthcare advertising industry.
Digital Asking the right questions around AI, with Brian Alexander, ... At BIO 2025, editor-in-chief Jonah Comstock spoke with Brian Alexander, CEO of Valo Health, about how he’s seeing the AI conversation evolve.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
